
Volume 10, Supplement 1 (Mar 2019)
Volume 10, Supplement 1 (Mar 2019)
Immuno-Oncology Therapy Essentials: Proactive Management of Immune-Related Adverse Events
This supplement, certified for CME/CE/CPE credit, is jointly provided by:
Meeting the Challenge of Immune-Related Adverse Events With Optimized Telephone Triage and Dedicated Oncology Acute Care
March 17, 2019
PD-1/PD-L1 Inhibitors for Non–Small Cell Lung Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
March 17, 2019
Checkpoint Inhibitor Immunotherapy for Head and Neck Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
March 17, 2019
Immune-Related Adverse Events From Immunotherapy: Incorporating Care Step Pathways to Improve Management Across Tumor Types
March 17, 2019
Advertisement
Current Issue


Vol 16
No 4
Jul/Aug 2025
The Impact of Federal Funding Cuts on Research Practice and Patient Care
Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO
July 14, 2025
Improving Use of Cytomegalovirus Negative and Irradiated Blood Products in an Outpatient Oncology Clinic
Susan Ezell, APRN, AGAC-NP
July 14, 2025
Supporting Administrative Time for Advanced Practitioners: A Comprehensive Approach
Meredith Beaton, RN, MSN, AGACNP, Andrea Edwards, PA-C, Wendy Vogel, MSN, FNP, AOCNP, FAPO, Et al.
July 14, 2025